Theravance Biopharma (TBPH) Reports Q4 Loss Per Share of $1.23

Theravance Biopharma (NASDAQ: TBPH) reported Q4 EPS of ($1.23), versus ($2.02) reported last year. Revenue for the quarter came in at $3.9 million, versus $1.4 million reported last year.

For earnings history and earnings-related data on Theravance Biopharma (TBPH) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Hyperscale Data acquires 48.5 acres to expand Michigan campus
• Argus starts SpaceX at Hold, sees record IPO as a multi-year re-rating challenge